Herbal Medicine Market Size, Share & Trends Analysis Report By Intervention (Ayurveda, Traditional Chinese Medicine), By Product Form (Tablet/Capsules, Powder), By Source, By Distribution Channel, By Region, And Segment Forecasts, 2024 - 2030

Herbal Medicine Market Size, Share & Trends Analysis Report By Intervention (Ayurveda, Traditional Chinese Medicine), By Product Form (Tablet/Capsules, Powder), By Source, By Distribution Channel, By Region, And Segment Forecasts, 2024 - 2030


Herbal Medicine Market Growth & Trends

The global herbal medicine market size is anticipated to reach USD 328.72 billion by 2030 and is projected to grow at a CAGR of 20.91% from 2024 to 2030, according to a new report by Grand View Research, Inc. There is a key shift towards healthier lifestyles, with individuals increasingly prioritizing their well-being and seeking natural alternatives to conventional healthcare. This inclination towards holistic wellness is accompanied by a growing preference for herbal remedies, perceived as gentler and safer options compared to synthetic drugs.

Consumers are increasingly seeking plant-based solutions due to concerns over the adverse effects of synthetic drugs, aligning with a broader shift towards holistic wellness and preventive healthcare. According to the World Health Organization (WHO), approximately 4 billion people i.e., 80% of the world's population use botanicals for some aspect of primary health care.

The advancements in extraction and formulation technologies have enhanced the efficacy and quality of botanical, making them more appealing to a broader audience. As scientific research continues to validate the benefits of remedies, consumer trust in these products is on the rise. Cultural and traditional practices also play a significant role, with the rich history of botanicals contributing to its growing popularity. With an expanding product range and distribution channels, including online platforms, these alternative therapy is becoming increasingly accessible and mainstream, driving further market growth.

There is an increasing demand for evidence-based medicine across all healthcare sectors, including botanicals. Clinical trials play a crucial role in advancing our understanding of traditional medicines and validating their efficacy, safety, and potential therapeutic benefits. In March 2024, 4 plant-based supplements, Yerba Buena, Ulasimang Bato, Tsaang Gubat, and Ampalaya, have passed clinical trials by the Institute of Herbal Medicine-National Institute of Health of University of the Philippines. These supplements have been proven to be effective in treating elevated relieving body pains, uric acid levels, lowering sugar levels in diabetics, and providing anti-colic relief for loose bowel movements and gallstones.

Herbal Medicine Market Report Highlights
  • Based on intervention. the ayurveda segment led the market with the largest revenue share of 27.7% in 2023, owing to its increasing awareness of the benefits of ayurvedic products and the growing adoption and acceptance of Ayurveda
  • The tablet/capsules segment held the market with the largest revenue share of 46.10% in 2023. This growth is attributable to the ease of consumption, precise dosing, and portability offered by this product form
  • Based on source, the roots segment led the market with the largest revenue share of 38.07% in 2023, owing to their traditional use in herbal remedies and various formulations
  • Based on distribution channel, the direct sales segment led the market with the largest revenue share of 67.62% in 2023, due to its benefits of personalized recommendations and customization of product as per need
Please note The report will be delivered in 2-3 business days upon order notification.


Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.2. Segment Definitions
1.2.1. Intervention
1.2.2. Product form
1.2.3. Source
1.2.4. Distribution Channel
1.2.5. Regional scope
1.2.6. Estimates and forecasts timeline
1.3. Research Methodology
1.4. Information Procurement
1.4.1. Purchased database
1.4.2. GVR’s internal database
1.4.3. Secondary sources
1.4.4. Primary research
1.4.5. Details of primary research
1.4.5.1. Data for primary interviews in North America
1.4.5.2. Data for primary interviews in Europe
1.4.5.3. Data for primary interviews in Asia Pacific
1.4.5.4. Data for primary interviews in Latin America
1.4.5.5. Data for primary interviews in MEA
1.5. Information or Data Analysis
1.5.1. Data analysis models
1.6. Market Formulation & Validation
1.7. Model Details
1.7.1. Commodity flow analysis (Model 1)
1.7.2. Approach 1: Commodity flow approach
1.7.3. Volume price analysis (Model 2)
1.7.4. Approach 2: Volume price analysis
1.8. List of Secondary Sources
1.9. List of Primary Sources
1.10. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Intervention
2.2.2. Product form
2.2.3. Source
2.2.4. Distribution channel
2.2.5. Regional outlook
2.3. Competitive Insights
Chapter 3. Herbal Medicine Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Market Dynamics
3.2.1. Market driver analysis
3.2.1.1. Rising health concerns
3.2.1.2. Growing consumer preference for natural remedies
3.2.1.3. Technological advancements in extraction and formulation of herbal medicines
3.2.2. Market restraint analysis
3.2.2.1. Regulatory challenges
3.2.2.2. Quality control issues
3.3. Herbal medicine Market Analysis Tools
3.3.1. Industry Analysis - Porter’s
3.3.1.1. Supplier power
3.3.1.2. Buyer power
3.3.1.3. Substitution threat
3.3.1.4. Threat of new entrant
3.3.1.5. Competitive rivalry
3.3.2. PESTEL Analysis
3.3.2.1. Political landscape
3.3.2.2. Technological landscape
3.3.2.3. Economic landscape
3.3.2.4. Pricing Analysis
3.3.3. Pricing Analysis
Chapter 4. Herbal Medicine Market: Intervention Estimates & Trend Analysis
4.1. Intervention Market Share, 2023 & 2030
4.2. Segment Dashboard
4.3. Herbal Medicine Market by Intervention Outlook
4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
4.4.1. Ayurveda
4.4.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.4.2. Apitherapy
4.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.4.3. Injections Bach Flower Therapy
4.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.4.4. Naturopathic Medicine
4.4.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.4.5. Traditional Chinese Medicine
4.4.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.4.6. Traditional Korean Medicine
4.4.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.4.7. Traditional Japanese Medicine
4.4.7.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.4.8. Traditional Mangolian Medicine
4.4.8.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.4.9. Traditional Tibetan Medicine
4.4.9.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.4.10. Zang Fu Theory
4.4.10.1. Market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 5. Herbal Medicine Market: Product Form Estimates & Trend Analysis
5.1. Product Form Market Share, 2023 & 2030
5.2. Segment Dashboard
5.3. Herbal Medicine Market by Product Form Outlook
5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
5.4.1. Powder
5.4.1.1. Market estimates and forecasts 2018 to 2030 (USD million)
5.4.2. Liquid/gel
5.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.4.3. Tablets/Capsules
5.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.4.4. Others
5.4.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 6. Herbal Medicine Market: Source Estimates & Trend Analysis
6.1. Source Market Share, 2023 & 2030
6.2. Segment Dashboard
6.3. Herbal Medicine Market by Source Outlook
6.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
6.4.1. Barks
6.4.1.1. Market estimates and forecasts 2018 to 2030 (USD million)
6.4.2. Leaves
6.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
6.4.3. Roots
6.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
6.4.4. Others
6.4.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 7. Herbal Medicine Market: Distribution Channel Estimates & Trend Analysis
7.1. Distribution Channel Market Share, 2023 & 2030
7.2. Segment Dashboard
7.3. Herbal Medicine Market by Distribution Channel Outlook
7.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
7.4.1. Direct Sales
7.4.1.1. Market estimates and forecasts 2018 to 2030 (USD million)
7.4.2. E- sales
7.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 8. Herbal Medicine Market: Regional Estimates & Trend Analysis
8.1. Regional Market Dashboard
8.2. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
8.3. North America
8.3.1. U.S.
8.3.1.1. Key Country dynamics
8.3.1.2. Regulatory framework/ reimbursement structure
8.3.1.3. Competitive scenario
8.3.1.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
8.3.2. Canada
8.3.2.1. Key Country dynamics
8.3.2.2. Regulatory framework/ reimbursement structure
8.3.2.3. Competitive scenario
8.3.2.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
8.4. Europe
8.4.1. UK
8.4.1.1. Key Country dynamics
8.4.1.2. Regulatory framework/ reimbursement structure
8.4.1.3. Competitive scenario
8.4.1.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
8.4.2. Germany
8.4.2.1. Key Country dynamics
8.4.2.2. Regulatory framework/ reimbursement structure
8.4.2.3. Competitive scenario
8.4.2.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
8.4.3. France
8.4.3.1. Key Country dynamics
8.4.3.2. Regulatory framework/ reimbursement structure
8.4.3.3. Competitive scenario
8.4.3.4. France market estimates and forecasts 2018 to 2030 (USD Million)
8.4.4. Italy
8.4.4.1. Key Country dynamics
8.4.4.2. Regulatory framework/ reimbursement structure
8.4.4.3. Competitive scenario
8.4.4.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
8.4.5. Spain
8.4.5.1. Key Country dynamics
8.4.5.2. Regulatory framework/ reimbursement structure
8.4.5.3. Competitive scenario
8.4.5.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
8.4.6. Norway
8.4.6.1. Key Country dynamics
8.4.6.2. Regulatory framework/ reimbursement structure
8.4.6.3. Competitive scenario
8.4.6.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
8.4.7. Sweden
8.4.7.1. Key Country dynamics
8.4.7.2. Regulatory framework/ reimbursement structure
8.4.7.3. Competitive scenario
8.4.7.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
8.4.8. Denmark
8.4.8.1. Key Country dynamics
8.4.8.2. Regulatory framework/ reimbursement structure
8.4.8.3. Competitive scenario
8.4.8.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
8.5. Asia Pacific
8.5.1. Japan
8.5.1.1. Key Country dynamics
8.5.1.2. Regulatory framework/ reimbursement structure
8.5.1.3. Competitive scenario
8.5.1.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
8.5.2. China
8.5.2.1. Key Country dynamics
8.5.2.2. Regulatory framework/ reimbursement structure
8.5.2.3. Competitive scenario
8.5.2.4. China market estimates and forecasts 2018 to 2030 (USD Million)
8.5.3. India
8.5.3.1. Key Country dynamics
8.5.3.2. Regulatory framework/ reimbursement structure
8.5.3.3. Competitive scenario
8.5.3.4. India market estimates and forecasts 2018 to 2030 (USD Million)
8.5.4. Australia
8.5.4.1. Key Country dynamics
8.5.4.2. Regulatory framework/ reimbursement structure
8.5.4.3. Competitive scenario
8.5.4.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
8.5.5. South Korea
8.5.5.1. Key Country dynamics
8.5.5.2. Regulatory framework/ reimbursement structure
8.5.5.3. Competitive scenario
8.5.5.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
8.5.6. Thailand
8.5.6.1. Key Country dynamics
8.5.6.2. Regulatory framework/ reimbursement structure
8.5.6.3. Competitive scenario
8.5.6.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
8.6. Latin America
8.6.1. Brazil
8.6.1.1. Key Country dynamics
8.6.1.2. Regulatory framework/ reimbursement structure
8.6.1.3. Competitive scenario
8.6.1.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
8.6.2. Mexico
8.6.2.1. Key Country dynamics
8.6.2.2. Regulatory framework/ reimbursement structure
8.6.2.3. Competitive scenario
8.6.2.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
8.6.3. Argentina
8.6.3.1. Key Country dynamics
8.6.3.2. Regulatory framework/ reimbursement structure
8.6.3.3. Competitive scenario
8.6.3.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
8.7. MEA
8.7.1. South Africa
8.7.1.1. Key Country dynamics
8.7.1.2. Regulatory framework/ reimbursement structure
8.7.1.3. Competitive scenario
8.7.1.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
8.7.2. Saudi Arabia
8.7.2.1. Key Country dynamics
8.7.2.2. Regulatory framework/ reimbursement structure
8.7.2.3. Competitive scenario
8.7.2.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
8.7.3. UAE
8.7.3.1. Key Country dynamics
8.7.3.2. Regulatory framework/ reimbursement structure
8.7.3.3. Competitive scenario
8.7.3.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
8.7.4. Kuwait
8.7.4.1. Key Country dynamics
8.7.4.2. Regulatory framework/ reimbursement structure
8.7.4.3. Competitive scenario
8.7.4.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 9. Competitive Landscape
9.1. Recent Developments & Impact Analysis, By Key Market Participants
9.2. Company/Competition Categorization
9.3. Vendor Landscape
9.3.1. List of key distributors and channel partners
9.3.2. Key customers
9.3.3. Key company market share analysis, 2023
9.3.4. Sheng Chang Pharmaceutical Company
9.3.4.1. Company overview
9.3.4.2. Financial performance
9.3.4.3. Intervention benchmarking
9.3.4.4. Strategic initiatives
9.3.5. Nordic Nutraceuticals
9.3.5.1. Company overview
9.3.5.2. Financial performance
9.3.5.3. Intervention benchmarking
9.3.5.4. Strategic initiatives
9.3.6. Herb Pharma
9.3.6.1. Company overview
9.3.6.2. Financial performance
9.3.6.3. Intervention benchmarking
9.3.6.4. Strategic initiatives
9.3.7. AYUSH Ayurvedic Pte Ltd.
9.3.7.1. Company overview
9.3.7.2. Financial performance
9.3.7.3. Intervention benchmarking
9.3.7.4. Strategic initiatives
9.3.8. Herbal Hills
9.3.8.1. Company overview
9.3.8.2. Financial performance
9.3.8.3. Intervention benchmarking
9.3.9. LKK Health Products Group Limited
9.3.9.1. Company overview
9.3.9.2. Financial performance
9.3.9.3. Intervention benchmarking
9.3.9.4. Strategic initiatives
9.3.10. International Chinese Body Care Houses
9.3.10.1. Company overview
9.3.10.2. Financial performance
9.3.10.3. Intervention benchmarking
9.3.10.4. Strategic initiatives
9.3.11. KindCare Medical Center
9.3.11.1. Company overview
9.3.11.2. Financial performance
9.3.11.3. Intervention benchmarking
9.3.11.4. Strategic initiatives
9.3.12. Pascoe Natural Medicine
9.3.12.1. Company overview
9.3.12.2. Financial performance
9.3.12.3. Intervention benchmarking
9.3.12.4. Strategic initiatives
9.3.13. Bionorica SE
9.3.13.1. Company overview
9.3.13.2. Financial performance
9.3.13.3. Intervention benchmarking
9.3.13.4. Strategic initiatives
9.3.14. Ming Chen Clinic
9.3.14.1. Company overview
9.3.14.2. Financial performance
9.3.14.3. Intervention benchmarking
9.3.14.4. Strategic initiatives
9.3.15. The Center for Natural and Integrative Medicine
9.3.15.1. Company overview
9.3.15.2. Financial performance
9.3.15.3. Intervention benchmarking
9.3.15.4. Strategic initiatives
9.3.16. Sinomedica
9.3.16.1. Company overview
9.3.16.2. Financial performance
9.3.16.3. Intervention benchmarking
9.3.16.4. Strategic initiatives
Chapter 10. Conclusion and Analyst Perspective

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings